numbers were increased at Credit Suisse through 2013. Company boosted guidance. Neutral rating and new $32 price target, Credit Suisse said.
estimates, target were raised at Citigroup. Shares are now seen reaching $19. Estimates were also increased on updated costs of various projects, Citigroup said. Buy rating.
(MDT - Get Report)
estimates were lowered through 2012 at Jefferies. Growth challenges, Jefferies said. Hold rating.
Medtronic target was reduced at Brean Murray to $42. Company lacks near-term catalysts, Brean Murray said.
numbers were increased at UBS. Shares are now seen reaching $57. Estimates were also increased on positive growth prospects, UBS said. Buy rating.
estimates were raised at Oppenheimer through 2012. Better-than-expected results. Outperform rating.
Nuance Comm. target was raised at ThinkEquity to $22. Company continues to deliver solid growth, ThinkEquity said. Hold rating.
Nuance Comm. estimates were increased at UBS through 2012. Mobile segment could be at an inflection point, UBS said. Maintain $29 price target and Buy rating.
numbers were lowered at Kaufman Bros. Shares are now seen reaching $2.35. Estimates were also cut, given the iPhone launch and higher network investment, Kaufman Bros. said. Hold rating.
was downgraded at JP Morgan from Overweight to Neutral. Valuation call, based on a $37 price target, JP Morgan said.
>To submit a news tip, email:
and become a fan on